Predict neutropenia, severe anemia, and thrombocytopenia caused by your drug candidate’s off-target toxicity to hematopoietic progenitor cells with our in vitro, IND-enabling, CFC assay services. We use primary cells and growth factors for lineage-specific cell differentiation to replicate the in vivo environment versus cell line-based studies. With decades of experience performing CFC assays, we can assist you with fit-for-purpose study design.
